HDAC-IN-89
HDAC-IN-89 is an inhibitor of HDAC1 (IC50: 0.95 nM), HDAC2 (IC50: 0.86 nM), HDAC3 (IC50: 1.06 nM) and HDAC8 (IC50: 4.24 nM) . HDAC-IN-89 blocks the cell cycle and induces apoptosis. HDAC-IN-89 has anti-tumor activity[1].
Product Specifications
UNSPSC
12352211
Target
HDAC
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
CC(C)[C@@H](C(N[C@H](/C=C/CCSSC[C@@H](C1=O)NC2=O)C(F)(F)C(N[C@@H]2C(C)C)=O)=O)NC(/C(N1)=C/C)=O
Molecular Formula
C24H35F2N5O5S2
Molecular Weight
575.69
References & Citations
[1]Song X, et al. Synthesis and biological evaluation of the Fluoro analog of Romidepsin with improved selectivity for class I histone deacetylases (HDACs) . Bioorg Chem. 2025 Mar 13;159:108348.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC6; HDAC8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS959562-01 0.02 mg (E-Coli)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details 
MBS959562-02 0.1 mg (E-Coli)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details 
MBS959562-03 0.02 mg (Yeast)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details MBS959562-04 0.1 mg (Yeast)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details MBS959562-05 0.02 mg (Baculovirus)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details MBS959562-06 0.02 mg (Mammalian-Cell)
Recombinant Pig Fatty acid-binding protein, liver (FABP1)
Ask
View Details